CAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime Powder

Product Details
Customization: Available
Varieties: General Disease Prevention Medicine
Component: Animal
Still deciding? Get samples of US$ 24500/kg
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Registered Capital
10000000 RMB
Plant Area
101~500 square meters
  • CAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime Powder
  • CAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime Powder
  • CAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime Powder
  • CAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime Powder
  • CAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime Powder
  • CAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime Powder
Find Similar Products

Basic Info.

Model NO.
HNB-298
Type
The First Class
Pharmacodynamic Influential Factors
Animal Species
Storage Method
Light Proof
Transport Package
Aluminium Foil Bag, Cardboard Drum
Trademark
HNB-Biotech
Origin
Shaanxi, China
Production Capacity
50kg/Month

Product Description

CAS 129496-10-2 Anti-parasitic Drug for Pets Milbemycin oxime Powder
CAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime Powder


CAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime Powder
Product name Milbemycin oxime
Cas No. 129496-10-2
Molecular Formula C63H88N2O14
Appearance White powder

Milbemycin oxime is a specific drug for the prevention and treatment of internal and external parasites in dogs and cats. It can effectively prevent and treat heartworm, hookworm, roundworm, whipworm, roundworm, roundworm and other internal parasites, as well as ectoparasites such as tricystis, scabies, lice and flea.
The main neurotransmitter of invertebrates (such as in vivo and in vivo parasites) is GABA (γ-aminobutyric acid). When Mirbxime enters the parasites, the binding force of GABA will be enhanced, so that chloride ions will continue to enter the cell membrane, and the membrane potential will continue to be hyperpolarized and nerve conduction will be interrupted, resulting in paralysis and death of parasites.
However, in mammals, only a small amount of GABA exists in the central nervous system. However, since Milbexime cannot pass the blood-brain barrier, it will not cause adverse effects on the nerve conduction of mammals, even for collie dogs that are generally considered to have high permeability of the blood-brain barrier.
Therefore, this drug has higher safety than ivermectin and abamectin, and will not cause adverse reactions of sheepdogs and Shetland dogs.
CAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime PowderCAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime PowderCAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime PowderCAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime PowderCAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime PowderCAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime PowderCAS 129496-10-2 Anti-Parasitic Drug for Pets Milbemycin Oxime Powder
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier